GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lineage Cell Therapeutics LCTX · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.08

+5.88%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Lineage Cell Therapeutics

Our reporting

Next results

5 Nov 2026

Due on 5 Nov 2026. Analysts expect earnings of -0.03 a share on revenue of $2.3m.

Past results

Reported against what analysts expected

6 Aug 202612 May 20265 Mar 20266 Nov 202512 Aug 202510 Mar 2025
Earnings per share-0.03-0.030.00-0.13-0.01-0.01
Forecast-0.03-0.02-0.04-0.02-0.02-0.04
Revenue$1.1m$1.7m$6.6m$3.7m$2.8m$2.9m
Forecast$1.8m$3.6m$2.0m$2.0m$1.5m$1.6m

Key events

  1. 31 Oct 19973-for-1 share split
  2. 5 Mar 1992Listed

Lineage Cell Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.